SILVER SPRING, MD. – A Food and Drug Administration advisory panel, citing numerous problems with cangrelor’s clinical trial program, has recommended against approval of the short-acting intravenous...
Atrial fibrillation is not a single disease, and specialists already have ways to distinguish one type from another and guide management. But new methods are emerging to better distinguish various...
SNOWMASS, COLO. – Survival in patients with advanced heart failure who receive a left ventricular assist device as destination therapy or as a bridge to transplant has increased dramatically in...
The data on cangrelor support approval of the fast-acting antiplatelet drug for reducing thrombotic cardiovascular events in patients with coronary artery disease who are undergoing percutaneous...
SNOWMASS, COLO. – The presence of preoperative dysfunction in more than any one of four key organ systems profoundly reduces survival in patients undergoing surgical aortic valve replacement, a study...
Newly released guidelines provide the first evidence-based recommendations for preventing stroke in women.
The document addresses the issues that uniquely increase stroke risk in women – pregnancy,...
For patients scheduled to undergo AF catheter ablation, estimating the extent of atrial fibrosis using delayed enhancement MRI can help distinguish those likely to respond from patients likely to...
Serial blood pressure measurements during young adulthood appear to predict the risk of subclinical coronary artery calcification, a surrogate for CVD risk, in middle age, according to a report...
Excess intake of sugar in the diet significantly raises the risk of cardiovascular mortality, independently of other risk factors, according to an analysis of National Health and Nutrition...
The Food and Drug Administration is reassessing the cardiovascular safety of approved testosterone treatments and urged physicians and patients to report side effects.
Two recent observational...
